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Aims: Similarly to patients presenting with acute coronary syndrome two kinds of
animal models were evaluated by cardiac magnetic resonance imaging (cMRI) and
electromechanical mapping (EMM). The balloon occlusion model character-
izes the features of patients receiving reperfusion therapy, the coil deployment
method imitated the features of “late comers”, who did not receive any reperfusion
therapy.
Methods and Results: Balloon occlusion in the left anterior descending coronary artery
(LAD balloon group) or coil deployment in the LAD (LAD coil group) or circumflex
artery (Cx coil group) were applied percutaneously to induce reperfused or non-reperfused
myocardial infarction (MI) in sixteen domestic pigs. Regional left ventricular viability data
were captured via cMRI and EMM. The unipolar voltage (UV) value was significantly
(p0.05) decreased in segments containing transmural and subendocardial late enhance-
ment as compared with viable segments in the LAD balloon (7.640.33, 6.50.26,
5.390.32 mV), LAD coil (8.960.56, 6.970.46, 5.970.5 mV) and Cx coil groups
(9.570.53, 6.060.61, 5.541.07 mV). Receiver operator characteristic analysis re-
vealed area under the curve 0.809 and 0.691 in the LAD infarct territory and 0.864, 0.855
(p0.05) in the Cx infarct territory for the UV compared to cMRI viability results as
transmural late enhancement or viable tissue and subendocardial late enhancement or
viable tissue, respectively.
Conclusion: Our study provides a comparison of baseline parameters in myocardial
infarcts of different pathomechanism and location via non-invasive and invasive methods
and emphasizes the application of both models in preclinical studies, especially if EMM
is utilized for both diagnostic and therapeutic purposes.
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Gender Disparities for Intravascular Ultrasound Minimal Lumen Area
Cutoff for Optimal Correlation with Fractional Flow Reserve in
Intermediate Lesions
Ron Waksman,1 Jacek Legutko,2 Jasvindar Singh,3 Quentin Orlando,4 Steven Marso,5
Timothy Schloss,6 James DeVries,7 Nicholas Palmer,8 Michael Haude,9
Stacy Swymelar,1 Rebecca Torguson1
1MedStar Washington Hospital Center, Washington, DC; 2University Hospital
Krakow, Krakow, Poland 3Barnes Jewish Hospital, St. Louis, MO; 4Hamot Medical
Center, Erie, PA; 5St. Luke’s Health Center, Kansas City, MO; 6Patients First,
Washington, MO; 7Dartmouth Medical Center, Lebanon, NH; 8Liverpool Heart and
Chest, Liverpool, United Kingdom 9Stadtische Kliniken Neuss, Neuss, Germany
Background: Assessment of intermediate coronary lesions is still challenging.
Fractional flow reserve (FFR) measurements of 0.8 or lower are considered
clinically significant for physiological ischemia. Intravascular Ultrasound minimal
lumen area (IVUS MLA) was suggested to correlate with FFR for the determi-
nation of significant Stenosis. This study aimed to examine gender differences for
the IVUS MLA cutoff.
Methods: The FIRST trial is a multi-center, prospective, international registry of
patients with intermediate coronary lesions defined as a stenosis of 40-80% by angiogra-
phy. A total of 350 patients, 367 lesions were enrolled into the study at 10 sites in the
United States and Europe. Patients were followed up to hospital discharge. The primary
end point was a correlation between MLA and FFR and to identity a cut-off value for
MLA corresponding to FFR of 0.8. This sub-analysis examines the differences and
correlations between males and females, where there were 260 males and 90 females in the
study population.
Results: A receiver operating characteristic curve (ROC) identified MLA 3.1
mm2 (sensitivity 64.1%, specificity 64.9%) as the best threshold value for FFR
0.8. The same analysis between men and women showed, the minimum lumen
area (MLA) cut-off for males was 3.19 mm2 (sensitivity 63.8%, specificity 64.7%,
r0.315), and 2.57 mm2 (sensitivity 65.0%, specificity 72.2%, r0.294) for
females.
Conclusion: Anatomic measurements of intermediate coronary lesions obtained by
IVUS show a moderate correlation to FFR values. The MLA cutoff for female is smaller
when compared to Male. These findings are correlated to smaller vessel size in female and
should be taken into account when IVUS MLA is used for assessment of severity of
intermediate lesions.
Lesion Characteristics
Overall
(n344)
Male
(n242)
Female
(n92)
P
Value
LAD 190 (56.9%) 133 (55.0%) 57 (62.0%) 0.249
LCX 60 (18.0%) 44 (18.2%) 16 (17.4%) 0.866
RCA 80 (24.0%) 62 (25.6%) 18 (19.6%) 0.247
Proximal 110 (32.9%) 86 (35.5%) 24 (26.1%) 0.101
Mid 198 (59.3%) 141 (58.3%) 57 (62.0%) 0.540
Distal 19 (5.7%) 12 (5.0%) 7 (7.6%) 0.350
Pre RVD 2.97  0.58 3.01  0.59 2.87  0.54 0.063
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The Execution and Management of a Complex Clinical Trial
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By providing evidence for best practice, randomized clinical trials play a critical role in
shaping the care of the public. We report the operational management systems that
enabled the successful execution of a landmark randomized clinical trial. We propose a
model for managing high-enrolling, multidisciplinary clinical trials. From 2007-2011 238
subjects were enrolled into TAVR Trial. All patients underwent robust screening
assessment(Figure 1A)which was reviewed by our Heart Team at our weekly conference.
The Heart Team incorporates expertise from multiple disciplines with subinvestigators
from cardiac surgery, cardiology, anesthesiology, neurology. Both research and clinical
studies were required during the following phases of care: screening, baseline, preopera-
tive, intraoperative, postoperative,discharge,1month,6month,and every year thereafter out
to 5 years (Figure 1B).A minimum of 2069 data points were captured to ensure
compliance. Safety reporting required review of 969 adverse events of which 80% were
significant, requiring review by the PI within 24 hours. Continual education and training
of all team members was required due to protocol amendments (8 total). Protocol required
specifics were necessary for all diagnostic studies. We screened 1000 patients. Rate of
enrollment increased from 2 patients/month to 24-32 patients/month. Weekly heart team
meetings facilitated contribution from all heart team members.THV clinic days were
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 2 , S u p p l S , 2 0 1 3 S35
N
U
R
SE
A
N
D
T
E
C
H
